Home/Filings/4/0001209191-23-039890
4//SEC Filing

Herrmann John A III 4

Accession 0001209191-23-039890

CIK 0001000694other

Filed

Jun 26, 8:00 PM ET

Accepted

Jun 27, 4:31 PM ET

Size

9.8 KB

Accession

0001209191-23-039890

Insider Transaction Report

Form 4
Period: 2023-06-25
Herrmann John A III
SVP, General Counsel
Transactions
  • Exercise/Conversion

    Common Stock

    2023-06-25+83312,111 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-06-258330 total
    Common Stock (833 underlying)
  • Tax Payment

    Common Stock

    2023-06-25$6.70/sh278$1,86311,833 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    3,384
Footnotes (3)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
  • [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
  • [F3]The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the June 25, 2020 grant date, in each case subject to continued employment with the Company through such vesting date.

Issuer

NOVAVAX INC

CIK 0001000694

Entity typeother

Related Parties

1
  • filerCIK 0001610928

Filing Metadata

Form type
4
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:31 PM ET
Size
9.8 KB